Life Science Investing Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
Life Science Investing Quantum-Si Highlights Significant Development Advancements for Proteus and Industry Leading Technology Pipeline at Investor & Analyst Day
Life Science Investing Quantum-Si to Highlight Significant Proteus Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day
Life Science Investing Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Life Science Investing Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
Life Science Investing Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing
Life Science Investing Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Seegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard
Locksley Confirms Continuous High Grade Mineralized Silver Corridor at its Mojave Project in California
Homerun Resources Inc. Closes Acquisition of Additional Mineral Rights in the Santa Maria Eterna Silica Sand District
